| # | Drug | Count |
|---|---|---|
| 0 | FLUOROURACIL | 45 |
| 1 | FLUOROURACIL CREAM, 0.5% | 45 |
| 2 | GEMCITABINE HYDROCHLORIDE | 41 |
| 3 | OXALIPLATIN | 40 |
| 4 | CAPECITABINE | 36 |
| 5 | GEMCITABINE | 25 |
| 6 | BEVACIZUMAB | 24 |
| 7 | CISPLATIN | 22 |
| 8 | PANITUMUMAB | 20 |
| 9 | IRINOTECAN HYDROCHLORIDE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 8 | 0.0071 |
| 1 | PEMIGATINIB | 5 | 0.0059 |
| 2 | IVOSIDENIB | 8 | 0.0037 |
| 3 | IRINOTECAN HYDROCHLORIDE | 18 | 0.0014 |
| 4 | PANITUMUMAB | 20 | 0.0012 |
| 5 | REGORAFENIB | 13 | 0.0011 |
| 6 | ADO-TRASTUZUMAB EMTANSINE | 7 | 0.0008 |
| 7 | GEMCITABINE HYDROCHLORIDE | 41 | 0.0008 |
| 8 | ENCORAFENIB | 7 | 0.0007 |
| 9 | FLUOROURACIL CREAM, 0.5% | 45 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 8 | 0.0037 |
| 1 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 4 | 0.0026 |
| 2 | Non-Standardized Fungal Allergenic Extract [EPC] | 2 | 0.0009 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 33 | 0.0007 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 4 | 0.0006 |
| 5 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 6 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 9 | 0.0004 |
| 7 | Oxytocic [EPC] | 1 | 0.0003 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 84 | 0.0003 |
| 9 | Bile Acid [EPC] | 7 | 0.0003 |